Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Comment by Yamahaon Jan 18, 2022 9:47am
121 Views
Post# 34327918

RE:RE:RE:RE:It's time to rise now, we need a news soon

RE:RE:RE:RE:It's time to rise now, we need a news soon
Smokey1958 wrote:

1. Not one company got approvals on the first day they said they were going to create a test (18 months).

2. Sorry, but wrong type of virus! No company is going to create a single vaccine to combat this. If this had been the case influenza would be history. On the other hand it is becoming apparent that any company that can create a test that can distinguish covid from the flu from a cold may very well hit the jackpot.

3. Agreed, leaving a loose end like the CE mark is bad marketing.

4. Ask Australia what happens when you back off the rules ....as I posted yesterday now they can't get rapid antigen tests fast enough. By the way BC just extended their rules.

5. There are many scientists that completely disagree with the Phizer CEO ....please post the links to his comments. I have shared the links for a completely opposite view. Thank you!

6. Sorry that you're out but investors will all make the decision that is right for them. 

In the meantime Morningstar's Fair Value sp continues to be well over $1.00 and the shorterm indicators on Barchart are a BUY. With no end in site for Omicron it will continue to be testing, testing, testing. Let's go FDA!!!

GLTY ...whenever your investment $ takes you!!!

 


Yamaha wrote:

stockmonster6 wrote: Yes, as vaccine and therapeutic technology increases and gets better it is only a matter of time before Pfizer creates the vaccine that actually innoculates against Covid 19 and any rapid test will be insignificant.

I hope it's this week.  6 months ago, THRM was running out of time.

I would like to hear about why we didn't sell units in Europe as was indicated last June.
 


Already too late, 18 months no approvals, 100000 EU order never met the conditional requirement of completing a clinical trial in one of the 27 member countries of the EU. CE is not an approval to sell Covid tests it's an accreditation only This is dead money imo Too Late most countries are rolling back the rules fast. Pfizer CEO says pandemic done by spring right or wrong no-one cares about salvia tests anymore Covid is already Endemic. It was a cool idea 18 months ago. Where's Narvinder? $300/share? Hahahaha I'm out.. GLTA




Albert Bourla, the CEO of Pfizer, said in an interview published late Sunday that he believes there will be a "return to normal life" sometime in the spring after over two years of dealing with the COVID-19 pandemic, Le Figaro French News
<< Previous
Bullboard Posts
Next >>